✦ LIBER ✦

A phase II study of biweekly paclitaxel and cisplatin chemotherapy for recurrent or metastatic esophageal squamous cell carcinoma: ERCC1 expression predicts response to chemotherapy

✍ Scribed by Jing Huang, Yi Zhou, Hongtu Zhang, Tao Qu, Yousheng Mao, Hongxia Zhu, Lanping Quan, Puyuan Xing, Jinwan Wang, Jie He, Ningzhi Xu, Yan Sun

Book ID: 118821722
Publisher: Springer US
Year: 2012
Tongue: English
Weight: 374 KB
Volume: 30
Category: Article
ISSN: 1357-0560
DOI: 10.1007/s12032-012-0343-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II trial of modified weekly irin

A phase II trial of modified weekly irinotecan and cisplatin for chemotherapy-naïve patients with metastatic or recurrent squamous cell carcinoma of the esophagus

✍ Dae Ho Lee; Heung Tae Kim; Ji-Youn Han; Sung Young Lee; Sung Jin Yoon; Hyae Youn 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 267 KB

Phase II study of use of a single cycle

Phase II study of use of a single cycle of induction chemotherapy and concurrent chemoradiotherapy containing capecitabine/cisplatin followed by surgery for patients with resectable esophageal squamous cell carcinoma: long-term follow-up data

✍ Dong Hoe Koo; Seung-Il Park; Yong-Hee Kim; Jong Hoon Kim; Hwoon-Yong Jung; Gin-H 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 265 KB